Five-day program included clinical observations and product science sessions

Vera Beauty said on Nov. 4 that it held its first “Vera Fellowship” from Oct. 20 to 24.


The program, planned and operated jointly with Airem Aesthetic Academy, brought together 24 leaders in aesthetic medicine, including 22 participants based in the United States. The participants included doctors, clinicians, medical directors, and operators of medical institutions and medical spas.


Vera Beauty is building a platform to help U.S. consumers understand and book aesthetic procedures and find verified medical professionals. The Vera Fellowship expands this business into medical professional education and professional exchanges between Korea and the United States.

Vera Beauty Hosts 'Vera Fellowship' for Korea-U.S. Aesthetic Medicine Exchange View original image

Over the five days, participants attended master classes led by Korean medical professionals, observed clinical practice at clinics, took part in product science sessions and personalized consultations, and experienced procedures. The curriculum covered procedures and technologies used in Korea, as well as patient assessments, combinations of procedures, and approaches to developing long-term treatment plans.


Jeisys Medical, Hugel, PharmaResearch, and Vaim participated as program sponsors. Participants took part in technical training provided by Jeisys Medical and exchanges with Hugel representatives. At the headquarters of PharmaResearch and Vaim, respectively, product science sessions focused on Rejuran and Juvelook.



Sun Lee, CEO of Vera Beauty, said, “The Vera Fellowship was designed to enable knowledge and market perspectives to flow in both directions. U.S. medical professionals could learn firsthand from Korea’s aesthetic medicine sector, while Korean partners could hear directly how U.S. medical professionals evaluate new procedures, technologies, and approaches to patient care.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily. All rights reserved. Unauthorized AI training and use prohibited.

Today’s Briefing